Vext Science, Inc.
VEXTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $27 | $35 | $25 | $70 |
| - Cash | $5 | $9 | $6 | $6 |
| + Debt | $40 | $39 | $38 | $14 |
| Enterprise Value | $62 | $65 | $57 | $77 |
| Revenue | $36 | $35 | $35 | $37 |
| % Growth | 3.4% | -1.7% | -4.9% | – |
| Gross Profit | $9 | $12 | $23 | $19 |
| % Margin | 24.9% | 34.6% | 65.2% | 50.2% |
| EBITDA | -$2 | $17 | $15 | $13 |
| % Margin | -5.6% | 49.9% | 42.4% | 34.4% |
| Net Income | -$22 | $4 | $11 | $5 |
| % Margin | -62.3% | 12.6% | 30.8% | 13.4% |
| EPS Diluted | -0.093 | 0.027 | 0.075 | 0.034 |
| % Growth | -448.7% | -64.5% | 122.5% | – |
| Operating Cash Flow | $3 | $4 | $6 | $12 |
| Capital Expenditures | -$1 | -$3 | -$9 | -$19 |
| Free Cash Flow | $2 | $2 | -$3 | -$7 |